title: The use of examination under anaesthesia and panendoscopy in patients presenting with oral cavity and oropharyngeal squamous cell carcinoma.
abstract: BACKGROUND
  Although examination under anaesthesia and panendoscopy (EUAP) has traditionally been used in the assessment of patients presenting with oral cavity and oropharyngeal squamous cell carcinoma (SCC), the era of modern medicine with its advanced imaging techniques has meant that the indications for this technique have potentially reduced.
  
  
  METHODS
  In an attempt to quantify the current use of EUAP in the UK, a structured telephone questionnaire was undertaken of 50 maxillofacial units. Information was gathered regarding whether the technique was adopted on a routine or selective basis. Likewise perceived disadvantages were sought.
  
  
  RESULTS
  Twenty-two units (44%) carried out EUAP on all patients presenting with oral cavity and oropharyngeal SCC. Of the remaining 28 units, all employed EUAP on a selective basis, the most commonly for the assessment of the primary tumour. The most common perceived disadvantage of carrying out EUAP routinely was its potential to increase the waiting time to definitive treatment.
  
  
  CONCLUSIONS
  These results suggest a gradual move towards the selective use of EUAP in patients presenting with oral cavity and oropharyngeal SCC.
authors.affiliation: Head and Neck Unit, The Royal Marsden Hospital, London, UK. c.kerawala@boltblue.com
authors.forename: Cyrus J
authors.initials: CJ
authors.lastname: Kerawala
authors.forename: Brian
authors.initials: B
authors.lastname: Bisase
authors.forename: Jon
authors.initials: J
authors.lastname: Lee
mesh_terms: D000758:Anesthesia; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000191:economics; D004724:Endoscopy / Q000191:economics / Q000379:methods*; D006801:Humans; D009062:Mouth Neoplasms / Q000175:diagnosis* / Q000191:economics; D009959:Oropharyngeal Neoplasms / Q000175:diagnosis* / Q000191:economics; D011795:Surveys and Questionnaires; D013997:Time Factors; D006113:United Kingdom; D014850:Waiting Lists
references.citation: Eur Arch Otorhinolaryngol. 2005 Jan;262(1):17-20
references.pmid: 15004709
references.citation: Laryngoscope. 2002 Mar;112(3):457-61
references.pmid: 12148854
references.citation: Semin Oncol. 1994 Jun;21(3):340-8
references.pmid: 8209265
references.citation: Ann Otol Rhinol Laryngol. 1996 Apr;105(4):262-6
references.pmid: 8604885
references.citation: Clin Oncol (R Coll Radiol). 2005 Dec;17(8):604-9
references.pmid: 16372485
references.citation: Cancer Treat Res. 2008;143:93-117
references.pmid: 18619215
references.citation: Rev Laryngol Otol Rhinol (Bord). 2007;128(1-2):3-9
references.pmid: 17633658
references.citation: Eur Arch Otorhinolaryngol. 2007 May;264(5):531-8
references.pmid: 17203307
references.citation: Ear Nose Throat J. 2001 Jan;80(1):49-50
references.pmid: 11209519
references.citation: Ann Otol Rhinol Laryngol. 1992 Feb;101(2 Pt 1):105-12
references.pmid: 1531402
references.citation: Head Neck. 2000 Aug;22(5):449-54; discussion 454-5
references.pmid: 10897102
references.citation: Laryngoscope. 2003 May;113(5):888-91
references.pmid: 12792328
references.citation: Otolaryngol Head Neck Surg. 2001 Feb;124(2):208-12
references.pmid: 11226943
references.citation: Eur J Cancer. 2001 Nov;37(17):2204-11
references.pmid: 11677108
references.citation: Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1329-33
references.pmid: 17308919
references.citation: Clin Otolaryngol. 2008 Apr;33(2):149-51
references.pmid: 18429872
references.citation: Laryngoscope. 1989 Dec;99(12):1267-73
references.pmid: 2601541